FMO5 and Parkinson disease: Modulating NADPH oxidases activity would represent a logical alternative to modify the course of PD, as it targets enzymatic complexes that are solely dedicated to the production of reactive oxygen species and that regulate cellular processes that are disrupted in PD (Fig. 4).